EBR Systems, Inc.

EBRCZ ·Healthcare, Medical Devices, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023
Operating Activities
Net Income $-48.8M $-40.8M $-35.0M
Depreciation & Amortization $403.0K $587.0K $752.3K
Depreciation
Amortization
Stock-Based Compensation $3.1M $1.7M $1.3M
Net Cash from Operating Activities $-53.2M $-41.2M $-32.7M
Investing Activities
Capital Expenditures $3.7M $273.0K $354.1K
Business Acquisitions
Net Cash from Investing Activities $7.8M $1.1M $-8.6M
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $46.8M $32.5M $40.5M
Net Change in Cash $1.5M $-7.7M $-877.6K
Free Cash Flow $-56.9M $-41.5M $-33.1M